FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2056475500> ?p ?o ?g. }

• W2056475500 endingPage "4414" @default.
• W2056475500 startingPage "4401" @default.
• W2056475500 abstract "In preparation for a phase I clinical trial using a combined cytotoxic/immunotherapeutic strategy with adenoviruses (Ad) expressing Flt3L (Ad-Flt3L) and thymidine kinase (Ad-TK) to treat glioblastoma (GBM), we tested the hypothesis that Ad-TK+GCV would be the optimal tumor-killing agent in relation to efficacy and safety when compared with other proapoptotic approaches.The efficacy and neurotoxicity of Ad-TK+GCV was compared with Ads encoding the proapoptotic cytokines [tumor necrosis factor-alpha, tumor necrosis factor-related apoptosis-inducing factor (TRAIL), and Fas ligand (FasL)], alone or in combination with Ad-Flt3L. In rats bearing small GBMs (day 4), only Ad-TK+GCV or Ad-FasL improved survival.In rats bearing large GBMs (day 9), the combination of Ad-Flt3L with Ad-FasL did not improve survival over FasL alone, whereas Ad-Flt3L combined with Ad-TK+GCV led to 70% long-term survival. Expression of FasL and TRAIL caused severe neuropathology, which was not encountered when we used Ad-TK+/-Ad-Flt3L. In vitro, all treatments elicited release of high mobility group box 1 protein (HMGB1) from dying tumor cells. In vivo, the highest levels of circulating HMGB1 were observed after treatment with Ad-TK+GCV+Ad-Flt3L; HMGB1 was necessary for the therapeutic efficacy of AdTK+GCV+Ad-Flt3L because its blockade with glycyrrhizin completely blocked tumor regression. We also showed the killing efficacy of Ad-TK+GCV in human GBM cell lines and GBM primary cultures, which also elicited release of HMGB1.Our results indicate that Ad-TK+GCV+Ad-Flt3L exhibit the highest efficacy and safety profile among the several proapoptotic approaches tested. The results reported further support the implementation of this combined approach in a phase I clinical trial for GBM." @default.
• W2056475500 created "2016-06-24" @default.
• W2056475500 creator A5022723078 @default.
• W2056475500 creator A5036408326 @default.
• W2056475500 creator A5040678451 @default.
• W2056475500 creator A5040825774 @default.
• W2056475500 creator A5040919449 @default.
• W2056475500 creator A5042507670 @default.
• W2056475500 creator A5043155961 @default.
• W2056475500 creator A5049664474 @default.
• W2056475500 creator A5052160380 @default.
• W2056475500 creator A5060565230 @default.
• W2056475500 creator A5065997663 @default.
• W2056475500 creator A5067218028 @default.
• W2056475500 creator A5067686943 @default.
• W2056475500 creator A5073424560 @default.
• W2056475500 creator A5080277287 @default.
• W2056475500 creator A5081152738 @default.
• W2056475500 creator A5082380342 @default.
• W2056475500 creator A5084729731 @default.
• W2056475500 date "2009-07-01" @default.
• W2056475500 modified "2023-10-16" @default.
• W2056475500 title "Release of HMGB1 in Response to Proapoptotic Glioma Killing Strategies: Efficacy and Neurotoxicity" @default.
• W2056475500 cites W1585144770 @default.
• W2056475500 cites W1647734909 @default.
• W2056475500 cites W1964421702 @default.
• W2056475500 cites W1973758213 @default.
• W2056475500 cites W1973811358 @default.
• W2056475500 cites W1977643218 @default.
• W2056475500 cites W1977982272 @default.
• W2056475500 cites W1978429511 @default.
• W2056475500 cites W1978484337 @default.
• W2056475500 cites W1981864943 @default.
• W2056475500 cites W1983914264 @default.
• W2056475500 cites W1984894292 @default.
• W2056475500 cites W1985528704 @default.
• W2056475500 cites W1993467626 @default.
• W2056475500 cites W1996322297 @default.
• W2056475500 cites W2004673553 @default.
• W2056475500 cites W2014380713 @default.
• W2056475500 cites W2016232550 @default.
• W2056475500 cites W2020496986 @default.
• W2056475500 cites W2021736304 @default.
• W2056475500 cites W2026842413 @default.
• W2056475500 cites W2034240238 @default.
• W2056475500 cites W2039267926 @default.
• W2056475500 cites W2043797928 @default.
• W2056475500 cites W2048428891 @default.
• W2056475500 cites W2055812104 @default.
• W2056475500 cites W2060417878 @default.
• W2056475500 cites W2072014675 @default.
• W2056475500 cites W2074762435 @default.
• W2056475500 cites W2084733813 @default.
• W2056475500 cites W2088412732 @default.
• W2056475500 cites W2093424661 @default.
• W2056475500 cites W2097189489 @default.
• W2056475500 cites W2098688060 @default.
• W2056475500 cites W2098850271 @default.
• W2056475500 cites W2102236923 @default.
• W2056475500 cites W2105100844 @default.
• W2056475500 cites W2107520546 @default.
• W2056475500 cites W2110347501 @default.
• W2056475500 cites W2111225862 @default.
• W2056475500 cites W2113476117 @default.
• W2056475500 cites W2116126240 @default.
• W2056475500 cites W2121571902 @default.
• W2056475500 cites W2121726690 @default.
• W2056475500 cites W2122526949 @default.
• W2056475500 cites W2141487162 @default.
• W2056475500 cites W2144434005 @default.
• W2056475500 cites W2147122201 @default.
• W2056475500 cites W2148276738 @default.
• W2056475500 cites W2159153230 @default.
• W2056475500 cites W3187649996 @default.
• W2056475500 cites W4241160352 @default.
• W2056475500 doi "https://doi.org/10.1158/1078-0432.ccr-09-0155" @default.
• W2056475500 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/2769255" @default.
• W2056475500 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19570774" @default.
• W2056475500 hasPublicationYear "2009" @default.
• W2056475500 type Work @default.
• W2056475500 sameAs 2056475500 @default.
• W2056475500 citedByCount "86" @default.
• W2056475500 countsByYear W20564755002012 @default.
• W2056475500 countsByYear W20564755002013 @default.
• W2056475500 countsByYear W20564755002014 @default.
• W2056475500 countsByYear W20564755002015 @default.
• W2056475500 countsByYear W20564755002016 @default.
• W2056475500 countsByYear W20564755002017 @default.
• W2056475500 countsByYear W20564755002018 @default.
• W2056475500 countsByYear W20564755002019 @default.
• W2056475500 countsByYear W20564755002020 @default.
• W2056475500 countsByYear W20564755002021 @default.
• W2056475500 countsByYear W20564755002022 @default.
• W2056475500 countsByYear W20564755002023 @default.
• W2056475500 crossrefType "journal-article" @default.
• W2056475500 hasAuthorship W2056475500A5022723078 @default.
• W2056475500 hasAuthorship W2056475500A5036408326 @default.
• W2056475500 hasAuthorship W2056475500A5040678451 @default.

• next